m1A Regulated Genes Modulate PI3K/AKT/mTOR and ErbB Pathways in Gastrointestinal Cancer
Open Access
- 1 October 2019
- journal article
- research article
- Published by Elsevier in Translational Oncology
- Vol. 12 (10) , 1323-1333
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 62 references indexed in Scilit:
- The role of m6A RNA methylation in cancerBiomedicine & Pharmacotherapy, 2019
- MODOMICS: a database of RNA modification pathways. 2017 updateNucleic Acids Research, 2017
- The m1A landscape on cytosolic and mitochondrial mRNA at single-base resolutionNature, 2017
- DiseaseMeth version 2.0: a major expansion and update of the human disease methylation databaseNucleic Acids Research, 2016
- RNA modifications: what have we learned and where are we headed?Nature Reviews Genetics, 2016
- Association of Somatic Mutations ofADAMTSGenes With Chemotherapy Sensitivity and Survival in High-Grade Serous Ovarian CarcinomaJAMA Oncology, 2015
- Molecular insights into HSD10 disease: impact of SDR5C1 mutations on the human mitochondrial RNase P complexNucleic Acids Research, 2015
- Trmt61B is a methyltransferase responsible for 1-methyladenosine at position 58 of human mitochondrial tRNAsRNA, 2012
- Crystal Structure of Thermus thermophilus tRNA m1A58 Methyltransferase and Biophysical Characterization of Its Interaction with tRNAJournal of Molecular Biology, 2008
- Dysregulation of the TSC-mTOR pathway in human diseaseNature Genetics, 2004